Separation Program Manager (Diabetes Order-to-Cash, Transition Services, Delayed Markets)

We anticipate the application window for this opening will close on - 10 Apr 2026 At Medtronic you can begin a life-long career of exploration and innovation, while helping champion healthcare access and equity for all. You’ll lead with purpose, breaking down barriers to innovation in a more connected, compassionate world. A Day in the Life At Medtronic, we push the limits of what technology, therapies, and services can do to help alleviate pain, restore health, and extend life. This role serves as a flexible program leader within the Separation Management Office (SMO), supporting the successful separation of Medtronic’s Diabetes business by driving critical operational priorities across Order-to-Cash, Procure-to-pay, Transition Services Agreement (TSA) exits, and delayed market readiness. As part of a complex, cross-functional program spanning operational, commercial, and supply chain functions, this role will lead Order-to-Cash (O2C) separation activities across assigned geographies while also supporting broader separation priorities as needed. The role will lead planning and execution of TSA exit activities and support delayed market close requirements to ensure operational readiness and continuity following separation. This individual will partner closely with the MiniMed separation team and enabling functions across Medtronic to coordinate execution and manage critical interdependencies across the separation program. At Medtronic, we bring bold ideas forward with speed and decisiveness to put patients first in everything we do. In-person exchanges are invaluable to our work. We’re working a minimum of 4 days a week onsite as part of our commitment to fostering a culture of professional growth and cross-functional collaboration as we work together to engineer the extraordinary. Responsibilities may include the following and other duties may be assigned. Lead and drive a cross‑functional program to support the separation of Medtronic’s Diabetes business, with accountability for planning, execution, and delivery of key operational milestones. Support Order-to-Cash (O2C) separation activities across assigned geographies, ensuring operational readiness and continuity of commercial and supply chain processes through separation milestones. Lead Procure-to-Pay (P2P) separation activities, including assessing current-state processes, defining the future-state operating model, and executing the transition of purchasing, vendor management, invoicing, and payment processes to ensure business continuity and compliance throughout the separation. Support coordination, execution, and ongoing management of Transition Services Agreement (TSA) activities across relevant functions, including governing service delivery, managing changes, and planning and executing TSA exits. Manage planning and execution for delayed market exits, including coordinating cross-functional readiness, regulatory and operational requirements, and interim operating models to ensure continuity of business operations until separation is achieved. Develop and manage integrated program plans spanning multiple workstreams, including Supply Chain, Manufacturing, Planning, Distribution, Quality, Regulatory, Finance, IT, Legal, and Commercial Operations. Direct day‑to‑day activities across matrixed teams by managing scope, timelines, resourcing, dependencies, and deliverables to ensure successful execution. Establish and maintain program governance, including decision forums, escalation paths, and status reporting. Identify, assess, and actively manage program risks and issues; develop mitigation strategies and drive timely resolution. Partner closely with functional and business leaders to ensure alignment with strategic objectives, operational requirements, and regulatory obligations. Establish meaningful metrics and dashboards to track program progress, readiness, and performance across workstreams. Support readiness for key milestones (e.g., separatio ... (truncated, view full listing at source)